New Results
Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics
View ORCID ProfileNaiara Santana-Codina, Amrita Singh Chandhoke, View ORCID ProfileQijia Yu, Beata Małachowska, Miljan Kuljanin, Ajami Gikandi, Marcin Stańczak, Sebastian Gableske, Mark P. Jedrychowski, David A. Scott, Andrew J. Aguirre, Wojciech Fendler, Nathanael S. Gray, View ORCID ProfileJoseph D. Mancias
doi: https://doi.org/10.1101/769703
Naiara Santana-Codina
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Amrita Singh Chandhoke
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Qijia Yu
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Beata Małachowska
bDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland
cDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA
Miljan Kuljanin
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Ajami Gikandi
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Marcin Stańczak
bDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland
Sebastian Gableske
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Mark P. Jedrychowski
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
cDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA
David A. Scott
dDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Andrew J. Aguirre
eDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Wojciech Fendler
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
bDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland
Nathanael S. Gray
dDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA
Joseph D. Mancias
aDivision of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Posted September 14, 2019.
Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics
Naiara Santana-Codina, Amrita Singh Chandhoke, Qijia Yu, Beata Małachowska, Miljan Kuljanin, Ajami Gikandi, Marcin Stańczak, Sebastian Gableske, Mark P. Jedrychowski, David A. Scott, Andrew J. Aguirre, Wojciech Fendler, Nathanael S. Gray, Joseph D. Mancias
bioRxiv 769703; doi: https://doi.org/10.1101/769703
Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics
Naiara Santana-Codina, Amrita Singh Chandhoke, Qijia Yu, Beata Małachowska, Miljan Kuljanin, Ajami Gikandi, Marcin Stańczak, Sebastian Gableske, Mark P. Jedrychowski, David A. Scott, Andrew J. Aguirre, Wojciech Fendler, Nathanael S. Gray, Joseph D. Mancias
bioRxiv 769703; doi: https://doi.org/10.1101/769703
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)